News | Neuro Imaging | January 02, 2018

Study results may help develop classification models to assist diagnosis of ADHD subtypes

MRI Shows Brain Differences Among ADHD Patients

January 2, 2018 — Information from brain magnetic resonance images (MRIs) can help identify people with attention deficit hyperactivity disorder (ADHD) and distinguish among subtypes of the condition, according to a study appearing online in the journal Radiology.

ADHD is a disorder of the brain characterized by periods of inattention, hyperactivity and impulsive behavior. The disorder affects 5 to 7 percent of children and adolescents worldwide, according to the ADHD Institute. The three primary subtypes of ADHD are predominantly inattentive, predominantly hyperactive/impulsive, and a combination of inattentive and hyperactive.

While clinical diagnosis and subtyping of ADHD is currently based on reported symptoms, psychoradiology, which applies imaging data analysis to mental health and neurological conditions, has emerged in recent years as a promising tool for helping to clarify diagnoses.

Study co-author Qiyong Gong, M.D., Ph.D., and colleagues at West China Hospital of Sichuan University in Chengdu, China, recently introduced an analytical framework for psychoradiology that involves cerebral radiomics — the extraction of a large amount of quantitative information from digital imaging features that can be mined for disease characteristics. Radiomics, combined with other patient characteristics, could improve diagnostic power and help speed appropriate treatment to patients.

“The main aim of the current study was to establish classification models that can assist the psychiatrist or clinical psychologist in diagnosing and subtyping of ADHD based on relevant radiomics signatures,” Gong said.

With the help of his West China Hospital colleagues Huaiqiang Sun, Ph.D., and Ying Chen, M.D., Ph.D., Gong studied 83 children, ranging in age from of 7 to 14, with newly diagnosed and never-treated ADHD. The group included children with the inattentive ADHD subtype and the combined subtype. Researchers compared brain MRI results with those of a control group of 87 healthy, similarly aged children. The researchers used a relatively new feature that allowed them to screen relevant radiomics signatures from more than 3,100 quantitative features extracted from the gray and white matter.

No overall difference was found between ADHD and controls in total brain volume or total gray and white matter volumes. However, differences emerged when the researchers looked at specific regions within the brain. Alterations in the shape of three brain regions (left temporal lobe, bilateral cuneus and areas around left central sulcus) contributed significantly to distinguishing ADHD from typically developing controls.

Within the ADHD population, features involved in the default mode network — a network of brain regions active when an individual is not engaged in a specific task — and the insular cortex — an area with diverse functions related to emotion — significantly contributed to discriminating the ADHD inattentive subtype from the combined subtype.

Overall, the radiomics signatures allowed discrimination of ADHD patients and healthy control children with 74 percent accuracy and discrimination of ADHD inattentive and ADHD combined subtypes with 80 percent accuracy.

“This imaging-based classification model could be an objective adjunct to facilitate better clinical decision making,” Gong said. “Additionally, the present study adds to the developing field of psychoradiology, which seems primed to play a major clinical role in guiding diagnostic and treatment planning decisions in patients with psychiatric disorders.”

The researchers plan to recruit more newly diagnosed ADHD patients to validate the results and learn more about imaging-based classification. They also intend to apply the analytic approach to other mental or neurological disorders and test its feasibility in a clinical environment, where the fully automatic analytic framework can be readily deployed, Gong said.

For more information: www.pubs.rsna.org/journal/radiology

Related Content

Feature | Magnetic Resonance Imaging (MRI) | Christine Book

August 10, 2022 — The imaging community has lost a legend, recognized for having revolutionized the field of diagnostic ...

Time August 10, 2022
arrow
News | Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

Time August 09, 2022
arrow
News | Breast Imaging

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

Time August 08, 2022
arrow
News | Pediatric Imaging

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

Time August 03, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time August 01, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

July 27, 2022 — Multitasking is not just an office skill. It’s key to functioning as a human, and it involves something ...

Time July 27, 2022
arrow
News | Pediatric Imaging

July 27, 2022 — St. Jude Children’s Research Hospital has announced that Zoltan Patay, MD, PhD, Department of Diagnostic ...

Time July 27, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

July 25, 2022 — For any drug to be successful in treating mental health or neurological problems, the medicine has to ...

Time July 25, 2022
arrow
Subscribe Now